bezafibrate has been researched along with pitavastatin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Akahane, M; Aoyagi, S; Awata, T; Hayashi, K; Inoue, I; Itoh, F; Katayama, S; Komoda, T; Kusama, H; Mastunaga, T; Tazawa, S | 1 |
2 other study(ies) available for bezafibrate and pitavastatin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
Topics: Anticholesteremic Agents; Bezafibrate; Blotting, Western; CCAAT-Enhancer-Binding Proteins; Cell Nucleus; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Gene Library; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Ligands; Liver; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Muscle, Skeletal; NF-kappa B; Nuclear Proteins; Protein Structure, Tertiary; Pyridines; Quinolines; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Retinoid X Receptors; Sequence Analysis, DNA; Sterol Regulatory Element Binding Protein 1; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 2002 |